BioCentury
ARTICLE | Financial News

InnaVirVax completes venture financing

February 20, 2012 8:00 AM UTC

InnaVirVax S.A., Evry, France Business: Infectious, Cancer Date completed: 2/12/12 Type: Venture financing Raised: $4.9 million Investors: Pradeyrol Developpement; Fa Diese; Fonds Regional de Co-Inves...